Multicentric Study on Infections of the Urinary Tract After Stent Removal (MINUS-trial).
Launched by UNIVERSITY HOSPITAL, GHENT · Apr 14, 2022
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The MINUS-trial is a study that aims to understand how often urinary tract infections (UTIs) occur after the removal of ureteral stents, which are small tubes placed in the urinary system during certain medical procedures. The trial will include adults aged 18 and older who have had a stent placed and are planning to have it removed either at a doctor's office or by themselves at home. Before the stent is removed, participants will provide a urine sample to ensure they do not have an infection, and they will answer questions about any UTI symptoms they might experience afterward.
To be eligible for this study, participants must be at least 18 years old, have had a stent placed during a procedure, and should not have any signs of infection before the stent is removed. Those with certain conditions, like a permanent catheter or recent UTIs, will not be included. Throughout the study, participants can expect to share their experiences and symptoms after stent removal, helping researchers gather valuable information on the risks of developing a UTI in different settings. This trial is important because it could help improve care for patients undergoing stent removal.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient aged 18 years or above
- • Stent placed during endoscopic procedure
- • A negative urine culture (UC) pre-operatively with a single dose of antibiotic prophylaxis peri-operatively
- • Stent removal is planned in outpatient setting of by the patient by using a string.
- • Able and willing to provide consent
- Exclusion Criteria:
- • Permanent indwelling catheter (transurethral catheter, suprapubic catheter, nephrostomy tubes)
- • Pregnant patients
- • Patient performing clean intermittent (self-)catheterization
- • Recent history (\<3 months) of demonstrated UTI
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gent, Eastern Flanders, Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials